CYBIN INC. — Form SCHEDULE 13D
Filed September 9, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D
— Neutral
significance 12/100
What the filing says
A Schedule 13D was filed on 2026-09-09 regarding Cybin Inc. (CIK 0001833141), a pharmaceutical preparations company. The filer appears to be an entity with CIK 0002116526, but the filing text provided is incomplete and does not contain the substantive details required to identify the acquirer's name, beneficial ownership percentage, share count, acquisition price, or strategic intent.
Why this rating
Filing metadata only; no material terms disclosed. Cannot assess deal size, ownership stake, or strategic impact without complete 13D content.
See more from September 9, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.